SUBSCRIBE
SUBSCRIBE

Catalent

NEWS
Drug Development
Biopharma Update on the Novel Coronavirus: June 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 22, 2020.
June 22, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: May 4
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 4, 2020.
May 4, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: April 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.
April 29, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Deals
Orgenesis completes sale of Masthercell subsidiary; receives approximately USD 127 million in net proceeds
Sale reflects culmination of successful CDMO strategy initiated in 2015 and 59 percent 5-year CAGR of Masthercell under Orgenesis’ leadership
February 14, 2020
 · 
5 min read
Business
Catalent to Buy Bristol-Myers’ Factory in Italy, Adding to Latest String of Expansions
The facility has acted as one of Bristol-Myers Squibb’s primary launch facilities for new drugs. After the deal is closed, Catalent will continue to manufacture Bristol-Myers Squibb’s current product portfolio at that location.
June 19, 2019
 · 
3 min read
 · 
Mark Terry
Bio NC
1Q2019 Life Science Growth Announcements
In the first quarter of 2019, more than 30 life science companies* announced expansions, new locations, increased funding, new trial and product launches and various other news pointing to a growing industry.
April 17, 2019
 · 
2 min read
 · 
Editorial Staff
Deals
Catalent Buys Paragon for $1.2 Billion to Build its Gene Therapy Vector Capabilities
Somerset, NJ-based CRO Catalent announced it is acquiring Baltimore-based Paragon BioServices for $1.2 billion.
April 15, 2019
 · 
3 min read
 · 
Mark Terry
Business
BioSpace Movers and Shakers Nov. 5
Biopharma companies make key appointments to fill leadership positions. Let’s take a look!
November 2, 2018
 · 
4 min read
 · 
Alex Keown
Biotech Beach
Up-and-Coming Automation Company Berkeley Lights Raises $95 Million
Berkeley Lights calls itself a digital cell biology company. It develops and markets tech platforms for what it calls “the intersection of biology, technology and information.”
October 15, 2018
 · 
2 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Drug Development
Triphase Accelerator to Present Investigational New Drug Enabling Data for TRPH-222
December 5, 2017
 · 
5 min read
Business
Catalent Collaborates With Grid Therapeutics to Develop a Novel Targeted Immuno-Oncology Therapy Approach Uses Catalent’s Proprietary GPEx Cell Line Technology
November 1, 2017
 · 
3 min read
Pharm Country
Catalent Announces Launch Of Private Offering Of $450 Million Of Senior Unsecured Notes Due 2026
October 10, 2017
 · 
7 min read
Business
Therapix Signs Formulation Development And Clinical Manufacturing Agreement With Catalent For THX-TS01
October 6, 2017
 · 
6 min read
Pharm Country
Catalent Announces Public Offering Of Common Stock To Fund Part Of Its Acquisition Of Cook Pharmica
September 26, 2017
 · 
6 min read
Business
Catalent Reports Fourth Quarter And Full Year 2017 Results
August 29, 2017
 · 
1 min read
Business
Catalent Announces Fourth Quarter and Fiscal Year 2017 Earnings Conference Webcast
July 20, 2017
 · 
1 min read
Pharm Country
Catalent To Host Spray Drying Technology Symposium To Highlight Solubility And Bioavailability Solutions
May 25, 2017
 · 
2 min read
Pharm Country
Catalent To Showcase Expanded Formulation Toolkit And Innovative Delivery And Manufacturing Technologies At CPhI North America
May 11, 2017
 · 
3 min read
Business
Catalent Reports Third Quarter Fiscal Year 2017 Results
May 5, 2017
 · 
2 min read
Load More